Evidence map›Paper›PMID 22029656›Full record

ArticleBMC neurology2011

Chronic cerebrospinal venous insufficiency in multiple sclerosis: clinical correlates from a multicentre study.

Stefano Bastianello, Alfredo Romani, Gisela Viselner, Enrico Colli Tibaldi, Elisabetta Giugni, Marta Altieri, Pietro Cecconi, Laura Mendozzi, Massimiliano Farina, Donatella Mariani and 8 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMC neurology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 49 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Review
  10. Article
  11. Article
  12. Chronic cerebrospinal venous insufficiency: masked multimodal imaging assessment.Multiple sclerosis (Houndmills, Basingstoke, England) · 2013
    Article
  13. Article
  14. Review
  15. Review
  16. CCSVI and MS: no meaning, no fact.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2013
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 3 countries.

Stefano BastianelloDepartment of Public Health and Neurosciences, IRCCS C, Mondino National Institute of Neurology Foundation, University of Pavia, Italy. stefano.bastianello@yahoo.it
Alfredo Romani
Gisela Viselner
Enrico Colli Tibaldi
Elisabetta Giugni
Marta Altieri
Pietro Cecconi
Laura Mendozzi
Massimiliano Farina
Donatella Mariani
Antonio Galassi
Claudio Quattrini
Marcello Mancini
Vincenzo Bresciamorra
Angela Lagace
Sandy McDonald
Giorgio Bono
Roberto Bergamaschi
Barrie Urology Group · CAIstituti di Ricovero e Cura a Carattere Scientifico · ITL'organizzazione Ospedale di Civitanova M · ITSapienza University of Rome · ITUniversity of Milan · ITUniversity of Pavia · ITOspedale di Circolo e Fondazione Macchi · ITUrology Foundation · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic cerebrospinal venous insufficiency (CCSVI) has recently been reported to be associated with multiple sclerosis (MS). However, its actual prevalence, possible association with specific MS phenotypes, and potential pathophysiological role are debated.

methodWe analysed the clinical data of 710 MS patients attending six centres (five Italian and one Canadian). All were submitted to venous Doppler sonography and diagnosed as having or not having CCSVI according to the criteria of Zamboni et al.

resultsOverall, CCSVI was diagnosed in 86% of the patients, but the frequency varied greatly between the centres. Even greater differences were found when considering singly the five diagnostic criteria proposed by Zamboni et al. Despite these differences, significant associations with clinical data were found, the most striking being age at disease onset (about five years greater in CCSVI-positive patients) and clinical severity (mean EDSS score about one point higher in CCSVI-positive patients). Patients with progressive MS were more likely to have CCSVI than those with relapsing-remitting MS.

conclusionThe methods for diagnosing CCSVI need to be refined, as the between-centre differences, particularly in single criteria, were excessively high. Despite these discrepancies, the strong associations between CCSVI and MS phenotype suggest that the presence of CCSVI may favour a later development of MS in patients with a lower susceptibility to autoimmune diseases and may increase its severity.

Indexed as

AdultBrainHumansMiddle AgedMultiple SclerosisPrevalenceSpinal CordUltrasonography, Doppler, TranscranialVenous Insufficiency

Identifiers

PMID22029656
PMCPMC3221625
OpenAlexW2167945750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.